These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24642531)

  • 1. Downregulation of ROCK2 through nanocomplex sensitizes the cytotoxic effect of temozolomide in U251 glioma cells.
    Wen X; Huang A; Liu Z; Liu Y; Hu J; Liu J; Shuai X
    PLoS One; 2014; 9(3):e92050. PubMed ID: 24642531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG-PEI/siROCK2 Protects Against Aβ42-Induced Neurotoxicity in Primary Neuron Cells for Alzheimer Disease.
    Liu Y; Yang X; Lei Q; Li Z; Hu J; Wen X; Wang H; Liu Z
    Cell Mol Neurobiol; 2015 Aug; 35(6):841-8. PubMed ID: 25776136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
    Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
    Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway.
    Chen L; Han L; Shi Z; Zhang K; Liu Y; Zheng Y; Jiang T; Pu P; Jiang C; Kang C
    Mol Med Rep; 2012 Feb; 5(2):575-9. PubMed ID: 22086271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.
    Wang Q; Qian J; Wang J; Luo C; Chen J; Hu G; Lu Y
    J Neurooncol; 2013 Mar; 112(1):73-82. PubMed ID: 23292182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2.
    Qi XC; Xie DJ; Yan QF; Wang YR; Zhu YX; Qian C; Yang SX
    Biochem Biophys Res Commun; 2013 Aug; 437(4):565-72. PubMed ID: 23850692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line.
    Zhou Y; Wang HD; Zhu L; Cong ZX; Li N; Ji XJ; Pan H; Wang JW; Li WC
    Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG-PEI/siROCK2 inhibits Aβ42-induced microglial inflammation via NLRP3/caspase 1 pathway.
    Liu Y; Zhang H; Peng A; Cai X; Wang Y; Tang K; Wu X; Liang Y; Wang L; Li Z
    Neuroreport; 2022 Jan; 33(1):26-32. PubMed ID: 34874326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.
    Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z
    Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment.
    Peng Y; Huang J; Xiao H; Wu T; Shuai X
    Int J Nanomedicine; 2018; 13():3467-3480. PubMed ID: 29942129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.
    Chai KM; Wang CY; Liaw HJ; Fang KM; Yang CS; Tzeng SF
    Oncotarget; 2014 Nov; 5(21):10901-15. PubMed ID: 25337721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways.
    Dai C; Zhang B; Liu X; Guo K; Ma S; Cai F; Yang Y; Yao Y; Feng M; Bao X; Deng K; Jiao Y; Wei Z; Junji W; Xing B; Lian W; Wang R
    Int J Cancer; 2013 Oct; 133(8):1982-93. PubMed ID: 23564480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases.
    Choi EJ; Cho BJ; Lee DJ; Hwang YH; Chun SH; Kim HH; Kim IA
    BMC Cancer; 2014 Jan; 14():17. PubMed ID: 24418474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.
    Lin J; Ji A; Qiu G; Feng H; Li J; Li S; Zou Y; Cui Y; Song C; He H; Lu Y
    Cancer Sci; 2018 Apr; 109(4):1001-1011. PubMed ID: 29427543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of ILK promotes temozolomide resistance in glioma cells.
    Liang F; Wang B; Bao L; Zhao YS; Zhang SM; Zhang SQ
    Mol Med Rep; 2017 Mar; 15(3):1297-1304. PubMed ID: 28138714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide does not influence the transcription or activity of matrix metalloproteinases 9 and 2 in glioma cell lines.
    Suzuki Y; Fujioka K; Ikeda K; Murayama Y; Manome Y
    J Clin Neurosci; 2017 Jul; 41():144-149. PubMed ID: 28408249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status.
    Chen L; Zhang J; Han L; Zhang A; Zhang C; Zheng Y; Jiang T; Pu P; Jiang C; Kang C
    Oncol Rep; 2012 Mar; 27(3):854-60. PubMed ID: 22075712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-κB/Bcl‑2 pathway.
    Qian C; Li P; Yan W; Shi L; Zhang J; Wang Y; Liu H; You Y
    Mol Med Rep; 2015 Mar; 11(3):1951-5. PubMed ID: 25405848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bak and Mcl-1 are essential for Temozolomide induced cell death in human glioma.
    Gratas C; Séry Q; Rabé M; Oliver L; Vallette FM
    Oncotarget; 2014 May; 5(9):2428-35. PubMed ID: 24811082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
    Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.